EDIRNA, Inc.
PrivateLast Round
Seed
Jul 5, 2023
Total Funding Raised
$500,000
Company Overview
EDIRNA, Inc. is a biotechnology company that develops RNA-editing therapeutics to address the root causes of genetic disorders and cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
RNA editingRNA therapeuticsdrug discoverygene therapygenetic medicinegenetic disorder treatmentRNA deliverybiotech R&Dgene modulationtherapeutic platformbiotech startuppreclinical development
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EDIRNA, Inc. Comparables
Compare EDIRNA, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Amber Bio | 87% | |
| Ascidian Therapeutics | 81% | |
| Shape Therapeutics | 80% | |
EDIRNA, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 5, 2023 |
EDIRNA, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EDIRNA, Inc.'s valuation, stock price, and market status.
Firmographic Details
HeadquartersGermantown, Maryland
Employee Range2
Year Founded2023
Last FundingJul 5, 2023